Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jinxin Fertility GroupHKSE:01951 -2.26%81 OCF Margin % is 23.59% as of Dec. 2025, which is 4% above its 10-year median of 22.65. GuruFocus rates HKSE:01951 with a GF Score™ of 81/100 and a GF Value™ of HK$3.74 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Jinxin Fertility Group ranks better than 86.77% on this metric.
The historical rank and industry rank for Jinxin Fertility Group's OCF Margin % or its related term are showing as below:
HKSE:01951'
s OCF Margin % Range Over the Past 10 Years
Min: 7.19 Med: 22.65 Max: 38.66
Current: 22.24
During the past 10 years, the highest OCF Margin % of Jinxin Fertility Group was 38.66%. The lowest was 7.19%. And the median was 22.65%.
HKSE:01951's OCF Margin % is ranked better than 86.77% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 8.08
vs HKSE:01951: 22.24
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01951 vs HCA, THC, DVA: OCF Margin % Comparison
For the Medical Care Facilities subindustry, Jinxin Fertility Group's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jinxin Fertility Group OCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jinxin Fertility Group's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Jinxin Fertility Group's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jinxin Fertility Group (HKSE:01951) has a OCF Margin % of 23.59% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Jinxin Fertility Group and its competitors. This is near median its historical median of 22.65. Over the past decade, Jinxin Fertility Group's OCF Margin % has ranged from 7.19 to 38.66. According to the industry distribution chart, Jinxin Fertility Group ranks #88 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 13.2%.
Is Jinxin Fertility Group's OCF Margin % too high?
Jinxin Fertility Group's current OCF Margin % of 23.59% is near median its 10-year median of 22.65. Over the past 10 years, this metric has ranged from a low of 7.19 to a high of 38.66. The Healthcare Providers & Services industry median OCF Margin % is 8.08. Jinxin Fertility Group's value of 23.59% is 192% above this industry median. Based on the distribution chart, Jinxin Fertility Group ranks #88 out of 665 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Jinxin Fertility Group has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Jinxin Fertility Group's OCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jinxin Fertility Group ranks #88 out of 665 companies for OCF Margin %. This places Jinxin Fertility Group in the top 13% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 8.08. Jinxin Fertility Group's value of 23.59% is 192% above this benchmark. Historically, Jinxin Fertility Group's own OCF Margin % has ranged from 7.19 to 38.66 over the past decade. While the company's 10-year median is 22.65 vs. the industry median of 8.08, Jinxin Fertility Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.08, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jinxin Fertility Group's current OCF Margin % of 23.59% is 192% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Jinxin Fertility Group and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jinxin Fertility Group's current OCF Margin % is 23.59%, which is near median its own 10-year median of 22.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinxin Fertility Group stock overvalued right now?
Based on GuruFocus' analysis, Jinxin Fertility Group (HKSE:01951) is currently considered Possible Value Trap. The stock's GF Value™ is HK$3.74, compared to a current price of HK$2.16 — trading 42.2% below its estimated fair value. The current OCF Margin % is 23.59%, which is near median its 10-year median of 22.65 and 192% above the Healthcare Providers & Services industry median of 8.08. Jinxin Fertility Group's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Jinxin Fertility Group (HKSE:01951), the current OCF Margin % is 23.59% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jinxin Fertility Group (HKSE:01951) Overvalued in 2026?
Based on GuruFocus' analysis, Jinxin Fertility Group stock appears to be undervalued.
The current stock price of HK$2.16 is trading 42.2% below its estimated GF Value™ of HK$3.74.
GuruFocus considers Jinxin Fertility Group to be Possible Value Trap.
Key valuation signals for HKSE:01951:
OCF Margin %: 23.59% (near median its 10-year median of 22.65)
GF Value™: HK$3.74 vs. price of HK$2.16 (42.2% below fair value)
Industry Position: 192% above the Healthcare Providers & Services median (#88 of 665)
No single metric tells the full story. See the HKSE:01951 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jinxin Fertility Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in providing IVF services in both China and the United States. The firm, through its subsidiary, is engaged in Assisted reproductive services, management services, ambulatory surgery centre facilities services, obstetrics, gynecology & pediatrics medical services, sales of medical consumables and equipment. and ancillary medical services. Geographically, the company generates a majority of its revenue from Greater China, with a small portion of revenue generated from Overseas Business.
81GF Score
Get the complete analysis for HKSE:01951
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01951 has been successfully added to your 
